Fig. 2.
Effect of belinostat on proliferation of human thyroid cancer xenografts growing in athymic mice. Graph of mean xenograft tumor volume (mm3) in belinostat-treated (100 mg/kg/5 day per week, I.P.) versus vehicle control-treated (treated similarly) mice over 52 days. Sixteen tumors (BHP2-7) were in both groups. (a) Graph of mean weights (in grams) of mice in the belinostat-treated and control-treated groups over the duration of experiment (b)